Novavax, Inc.
ロング

NVAX to Head Higher in the Coming Weeks?

This is the first tap of the original low outside of a major trend break. It is also the 11.4 fib level of the breakout move. With price ranging between $87-$126, I'd expect for $126 to be tested again.

We do have several catalyst coming down the pipeline as well. Phase 2 results, Phase 3 results, EU Deal is still in limbo, FDA approval, then actual sales of the vaccine if approved. With this pattern, I'm expecting a sharp V correction into new highs.

We'll see.
Trend Analysis

他のメディア:

免責事項